Bildiriler

Bildiri Adı Yazarlar Yayın Yeri Basım Tarihi Açıklama
1Evaluation Of The Antioxidant Effect Of Selenium Nanoparticles Biosynthesis Mediated By Purple Basil (Ocimum Basilicum L.)KÖSEOĞLU SENA, YEŞİLOT ŞÜKRİYE, AYDIN ACAR ÇİĞDEM1. INTERNATIONAL BLACKSEA SCIENTIFIC RESEARCH AND INNOVATION CONGRESS31.12.2023Tam metin bildiri, Basılı+Elektronik, TRABZON
2EVALUATION OF THE IN VITRO ANTIOXIDANT ACTIVITY OF BLUE BUTTERFLY (Clitoria ternatea L.,) AQUEOUS EXTRACTYILDIRIM SIDIKA, YEŞİLOT ŞÜKRİYE, AYDIN ACAR ÇİĞDEM7. INTERNATIONAL SCIENTIFIC RESEARCH AND INNOVATION CONGRESS28.12.2023Tam metin bildiri, Basılı+Elektronik, ANKARA
3Evaluation Of Antioxidant Activity Of Aronia Aqueous Plant Extract Using DPPH MethodKIYAK FUNDA GÜL, AYDIN ACAR ÇİĞDEM, YEŞİLOT ŞÜKRİYE4. INTERNATIONAL MEDITERRANEAN SCIENTIFIC RESEARCH CONGRESS11.12.2023Tam metin bildiri, Basılı+Elektronik, ADANA
4Antioxidant Activity Of Echinacea (Echinacea angustifolia) Flower ExtractKIYAK FUNDA GÜL, AYDIN ACAR ÇİĞDEM, YEŞİLOT ŞÜKRİYE4. INTERNATIONAL MEDITERRANEAN SCIENTIFIC RESEARCH CONGRESS11.12.2023Tam metin bildiri, Basılı+Elektronik, ADANA
5ORGANIC OILS USED IN WOUND HEALING IN ALTERNATIVE MEDICINEKIYAK FUNDA GÜL, AYDIN ACAR ÇİĞDEM1. INTERNATIONAL ULUDAĞ SCIENTIFIC RESEARCH CONGRESS17.07.2023Tam metin bildiri, Basılı+Elektronik, BURSA
6ANTIBACTERIAL PROPERTIES OF SELENIUM NANOPARTICULESERDEM ECEM, AYDIN ACAR ÇİĞDEM4. INTERNATIONAL HASANKEYF SCIENTIFIC RESEARCH AND INNOVATION CONGRESS01.05.2023Tam metin bildiri, Basılı+Elektronik, BATMAN
7MODERN WOUND DRESSING: SILVER NANOPARTICLESSARI BERFİN RUMEYSA, AYDIN ACAR ÇİĞDEM6.International Health Science and Life Congress12.03.2023Tam metin bildiri, Elektronik, BURDUR
8Plant-Mediated Synthesis Of Silver Nanoparticles As An Antibacterial AgentSARI BERFİN RUMEYSA, AYDIN ACAR ÇİĞDEM, YEŞİLOT ŞÜKRİYE3. INTERNATIONAL DICLE SCIENTIFIC RESEARCH AND INNOVATION CONGRESS30.11.2022Tam metin bildiri, Elektronik, DİYARBAKIR
9Assessment of in vitro antioxidant and antibacterial activities of Gilaburu (Viburnum opulus L.) extractYEŞİLOT ŞÜKRİYE, AYDIN ACAR ÇİĞDEM, SARI BERFİN RUMEYSA3. INTERNATIONAL DICLE SCIENTIFIC RESEARCH AND INNOVATION CONGRESS30.11.2022Tam metin bildiri, Elektronik, DİYARBAKIR
10Anti-Infective Effects Of Silver Nanoparticles On Dialysis CathetersCEYLAN HATİCE, SARI BERFİN RUMEYSA, AYDIN ACAR ÇİĞDEM2.INTERNATIONAL MARMARA SCIENTIFIC RESEARCH AND INNOVATION CONGRESS30.04.2022Tam metin bildiri, Elektronik, İSTANBUL
11Microwave-Assisted Biological Synthesis Of Silver Nanoparticles Using Aqueous Extract Of Thymus Capitatus And Their Antibacterial ActivitySARI BERFİN RUMEYSA, AYDIN ACAR ÇİĞDEM2.INTERNATIONAL MARMARA SCIENTIFIC RESEARCH AND INNOVATION CONGRESS30.04.2022Tam metin bildiri, Elektronik, İSTANBUL
12RESVERATROL AND AVOCADO OIL PRETREATMENT ATTENUATES PARACETAMOL-INDUCED LIVER INJURY IN RATSGÖKKAYA ERDİ ONUR, YEŞİLOT ŞÜKRİYE, ÖZGÖÇMEN MELTEM, AYDIN ACAR ÇİĞDEM3. Uluslararası Sağlık Bilimleri ve İnovasyon Kongresi26.01.2021Özet bildiri, Basılı, ANKARA
13Successful green synthesis of gold nanoparticles using grape seed extract and their combined effects with gemcitabine against colon cancer cells (HT29)GENÇ SELİM,PEHLİVANOĞLU SURAY,AYDIN ACAR ÇİĞDEM,YEŞİLOT ŞÜKRİYE3rd International Health Science and Life Congress04.06.2020Özet bildiri, Elektronik, BURDUR
14The Cytotoxicity and Caspase-Mediated Apoptotic Effect of Biologically Synthesized SilverNanoparticles from Lavender Extract on Human Glioblastoma U87MG CellsŞİMŞEK AYSEL,PEHLİVANOĞLU SURAY,AYDIN ACAR ÇİĞDEMVI. International Congress on Natural and Health Sciences25.03.2020Özet bildiri, Elektronik, KONYA
15Lactobacillus delbrueckii subsp. bulgaricus upregulates prostaglandin E2 production and downregulates cellmigration of human bone marrow mesenchymal stem cellsPEHLİVANOĞLU SURAY,AYDIN ACAR ÇİĞDEM3rd International Eurasian Conference on Biological and Chemical Sciences21.03.2020Özet bildiri, Elektronik, ANKARA
16Green synthesis of silver nanoparticles using Rosa canina extract and its antiproliferative effect against breast cancer cells (MCF-7)AL SEMERCİ FATMA,PEHLİVANOĞLU SURAY,AYDIN ACAR ÇİĞDEM1st International Congress of Medical Sciences, and Biotechnology21.01.2020Özet bildiri, Basılı, UŞAK
17Anti-metastatic activity and anti-proliferative activity of biologically synthesized silver nanoparticles on human colonadenocarcinoma cell line HT29AYDIN ACAR ÇİĞDEM,PEHLİVANOĞLU SURAY2. International Conference on Technology and Science16.11.2019Özet bildiri, Elektronik, BURDUR
18Evaluation of anticancer activity of synthesized silver nanoparticles using zingeber officinale extractAYDIN ACAR ÇİĞDEM,GÖRGİŞEN GÖKHAN3rd International Congress on Advances in Bioscience and Biotechnology (ICABB)29.07.2019Özet bildiri, Elektronik,
19Paracetamol Inhibits Insulin Receptor Substrate 1 Protein Activation in Glioblastoma Cell LineGÖRGİŞEN GÖKHAN,ÖKSÜZ ERSOY,AYDIN ACAR ÇİĞDEM6th International Symposium on Academic Studies in Health and Sport Sciences16.06.2019Özet bildiri, Elektronik,
20Nursing Students’ Perspective on the BiosciencesYEŞİLOT ŞÜKRİYE,AYDIN ACAR ÇİĞDEM,DÖNMEZ SONER,DİLEK ÖMER GÜRKAN2nd International Health Sciences and Life Congress27.04.2019Özet bildiri, Basılı, BURDUR
21Elektrokimyasal Yöntemlerle miRNA TespitiDÖNMEZ SONER,AYDIN ACAR ÇİĞDEM1st International Health Science and Life Congress10.05.2018Tam metin bildiri, Elektronik, BURDUR
22Frequency of chromosomal abnormalities in patients with Multiple MyelomaAYDIN ACAR ÇİĞDEM,HANGÜL CEREN,SALİM OZAN,YÜCEL ORHAN KEMAL,KARAÜZÜM SİBELEuropean Society of Human Genetics Congress 201624.05.2016Özet bildiri, Elektronik, BARSELONA
23Evaluation of MDM2 gene copy number alterations in chronic lymphocytic leukaemia patients with fluorescent in situ hybridizationKARAÜZÜM SİBEL,DARBAŞ ŞULE,AYDIN ÇİĞDEM,YÜCEL ORHAN KEMAL,AKKAYA BAHAR,SALİM OZAN10 th European Cytogenetics Conference, Strasbourg, France04.07.2015Özet bildiri, Basılı,
24Monosomy 7 and ring marker chromosome derived from chromosome 7 in a patient with MDS RAEB 2 A case reportAYDIN ÇİĞDEM,YÜCEL ORHAN KEMAL,SALİM OZAN,ÜNDAR LEVENT,AKKAYA BAHAR,KARAÜZÜM SİBEL10 th European Cytogenetics Conference, Strasbourg, Fransa04.07.2015Özet bildiri, Basılı,
25Evaluation of TEL AML1 fusion and additional abnormalities involving TEL and or AML1 genes using FISH technique in patients with childhood acute lymphoblastic leukemiaMANGUOĞLU AYDEMİR AYŞE ESRA,AYDIN ÇİĞDEM,ÇETİN ZAFER,TAYFUN FUNDA,ALTIOK CLARK ÖZDEN,KÜPESİZ OSMAN ALPHAN,AKKAYA BAHAR,KARAÜZÜM SİBEL10 th European Cytogenetics Conference, Strasbourg, France04.07.2015Özet bildiri, Basılı,
26Monozomi 7 MDS RAEB /PNH Hastalığı: Hipometilasyon?, Kompleman İnhibisyonu?, Allojenik Kök Hücre Nakli?YÜCEL ORHAN KEMAL,SALİM OZAN,ERDEM RAMAZAN,ILTAR UTKU,AYDIN ACAR ÇİĞDEM,KARAÜZÜM SİBEL40.Ulusal Hematoloji Kongresi25.10.2014Özet bildiri, Basılı, ANTALYA
27Kronik Lenfositik Lösemili olgularda MDM2 onkogeninin aktivasyonunun belirlenmesiŞULE DARBAŞ,SALİM OZAN,YÜCEL ORHAN KEMAL,ÜNDAR LEVENT,AYDIN ACAR ÇİĞDEM,KARAÜZÜM SİBEL40.Ulusal Hematoloji Kongresi25.10.2014Özet bildiri, Basılı, ANTALYA
28Plazmasitom ile prezente olan IgD lambda miyelomSALİM OZAN,YÜCEL ORHAN KEMAL,ERDEM RAMAZAN,ILTAR UTKU,AKKAYA BAHAR,AYDIN ACAR ÇİĞDEM,ÜNDAR LEVENT40.Ulusal Hematoloji Kongresi25.10.2014Özet bildiri, Basılı, ANTALYA
29Monozomi 7 ye eşlik eden 7 numaralı kromozom orjinli ring marker kromozoma sahip MDS RAEB 2 tanılı bir olgu sunumuAYDIN ACAR ÇİĞDEM,YÜCEL ORHAN KEMAL,SALİM OZAN,ÜNDAR LEVENT,KARAÜZÜM SİBEL40.Ulusal Hematoloji Kongresi25.10.2014Özet bildiri, Basılı, ANTALYA
30FLT3 ITD ve veya FLT3 D835 ve veya NPM1 pozitif Akut myeloid lösemi olguları Tek merkez deneyimiSALİM OZAN,YÜCEL ORHAN KEMAL,TOYLU ASLI,ILTAR UTKU,ERDEM RAMAZAN,AYDIN ACAR ÇİĞDEM,ALTIOK CLARK ÖZDEN,KARAÜZÜM SİBEL,AYŞEN TİMURAĞAOĞLU,ÜNDAR LEVENT40.Ulusal Hematoloji Kongresi25.10.2014Özet bildiri, Basılı, ANTALYA
31Akut promiyelositik lösemi olgusunda ilk kez tanımlanan klonal ek sitogenetik bozukluk t(6:10).SALİM OZAN,ERDEM RAMAZAN,AYDIN ACAR ÇİĞDEM,YÜCEL ORHAN KEMAL,ILTAR UTKU,TOYLU ASLI,ALTIOK CLARK ÖZDEN,KARAÜZÜM SİBEL,ÜNDAR LEVENT40.Ulusal Hematoloji Kongresi25.10.2014Özet bildiri, Basılı, ANTALYA
32A rare transformation case report from Chronic Lymphocytic Leukemia to Multiple MyelomaHANGÜL CEREN,AYDIN ACAR ÇİĞDEM,YÜCEL ORHAN KEMAL,SALİM OZAN,KARAÜZÜM SİBELAmerican Society of Human Genetics 64th Annual Meeting22.10.2014Özet bildiri, Basılı, SAN DİEGO, KALİFORNİA
33An uncommon coincidation of multiple myeloma and myelodysplastic syndromeKARAÜZÜM SİBEL,AYDIN ACAR ÇİĞDEM,SALİM OZAN,YÜCEL ORHAN KEMALAmerican Society of Human Genetics 64 th Annual Meeting22.10.2014Özet bildiri, Basılı, SAN DİEGO, KALİFORNİA
34Non obese diabetes resistant NOR mice are extremely susceptible to the toxic effects of streptozotocin reflected by high Glut2 expressions in pancreas and liverKAHRAMAN SEVİM,ELPEK GÜLSÜM ÖZLEM,AYDIN ACAR ÇİĞDEM,DİRİCE ERCÜMENT,ŞANLIOĞLU AHTER DİLŞADBeta Cells in Health and Disease.22.05.2014Özet bildiri, Basılı, KOCAELİ
35Diyabete dirençli NOR farelerin pankreas ve karaciğerlerinde yüksek Glut2 ekspresyonu diyabetik ajan streptozotosine karşı aşırı duyarlılık nedenidirKAHRAMAN SEVİM,ELPEK GÜLSÜM ÖZLEM,AYDIN ACAR ÇİĞDEM,DİRİCE ERCÜMENT,ŞANLIOĞLU AHTER DİLŞAD50. Ulusal Diyabet Kongresi, Antalya07.04.2014Özet bildiri, Basılı, ANTALYA
36inv (4)(p13q13) kromozom anomalisine sahip esansiyel trombositemi tanılı olgu sunumuAYDIN ACAR ÇİĞDEM,YÜCEL ORHAN KEMAL,SALİM OZAN,KARAÜZÜM SİBELXIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi. Kuşadası, Aydın30.10.2013Özet bildiri, Basılı, AYDIN
37Çocukluk çağı akut lenfoblastik lösemili hastalarda floresan in situ hibridizasyon ile TEL AML1 füzyonu ve TEL AML1 genlerini içeren ek anomalilerin değerlendirilmesiAYDIN ACAR ÇİĞDEM,ÇETİN ZAFER,TAYFUN KÜPESİZ FUNDA,KÜPESİZ OSMAN ALPHAN,KARAÜZÜM SİBELXIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi30.10.2013Özet bildiri, Basılı, AYDIN
38Differential Expression of GLUT2 in Pancreatic Islets Affects Streptozotocin Sensitivity in NOD and NOR miceKAHRAMAN SEVİM,AYDIN ACAR ÇİĞDEM,ELPEK GÜLSÜM ÖZLEM,DİRİCE ERCÜMENT,ŞANLIOĞLU AHTER DİLŞAD73 rd American Diabetes Association (ADA) Scientific Sessions. Chicago, IL.25.06.2013Özet bildiri, Basılı, CHiCAGO
39Endometrium Karsinomunda Ölümcül TRAIL Ligand ve Reseptör Ekspresyon Profilinin Tümör Evreleri İle İlişkilerinin BelirlenmesiAYDIN ACAR ÇİĞDEM,BİŞGİN ATIL,ŞANLIOĞLU AHTER DİLŞAD,PEŞTERELİ HADİCE ELİF,ERDOĞAN GÜLGÜN,ÖZBUDAK İREM HİCRAN,ŞİMŞEK TAYUP,ŞANLIOĞLU SALİHIV. Multidisipliner Kanser Araştırma Kongresi16.12.2012Özet bildiri, Basılı, BURSA
40Kronik faz Ph KML olgusunda gözlenen t(33)(q29q23), t (411) (q21q23), t(1118)(q10q10) translokasyonlarıÇETİN ZAFER,SALİM OZAN,AYDIN ACAR ÇİĞDEM,YÜCEL ORHAN KEMAL,ÜNDAR LEVENT,KARAÜZÜM SİBEL38. Ulusal Hematoloji Kongresi03.11.2012Özet bildiri, Basılı, ANTALYA
41Kronik Lenfositik Lösemili Hastalarda Sitogenetik ve Moleküler Sitogenetik BulgularTek Merkez DeneyimiAYDIN ACAR ÇİĞDEM,SALİM OZAN,ÇETİN ZAFER,YÜCEL ORHAN KEMAL,TİMURAĞAOĞLU AYŞEN,KARADOĞAN İHSAN,ÜNDAR LEVENT,KARAÜZÜM SİBEL38. Ulusal Hematoloji Kongresi03.11.2012Özet bildiri, Basılı, ANTALYA
4217P DELESYONUNA SAHİP MULTİPLE MYELOMA VE KRONİK LENFOSİTER LÖSEMİ TANILI OLGULARDA MOLEKÜLER SİTOGENETİK MARKIRLAR VE TERAPİ SONUÇLARININ İNCELENMESİ.KARAÜZÜM SİBEL,SALİM OZAN,ÇETİN ZAFER,AYDIN ACAR ÇİĞDEM,YÜCEL ORHAN KEMAL,TİMURAĞAOĞLU AYŞEN,KARADOĞAN İHSAN,ÜNDAR LEVENT38. Ulusal Hematoloji Kongresi03.11.2012Özet bildiri, Basılı, ANTALYA
43Diabetogenic response to streptozotocin varies among NOD and NOR miceKAHRAMAN SEVİM,AYDIN ACAR ÇİĞDEM,ELPEK GÜLSÜM ÖZLEM,DİRİCE ERCÜMENT,ŞANLIOĞLU AHTER DİLŞADCollaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy.29.10.2012Özet bildiri, Basılı, VERSAİLLES
44Pancreatic acinar cells respond differentially to diabetic agents Streptozotocin and CyclophosphamidKAHRAMAN SEVİM,DİRİCE ERCÜMENT,ELPEK GÜLSÜM ÖZLEM,AYDIN ACAR ÇİĞDEM,BALCI MUSTAFA KEMAL,ÖMER ABDULKADİR,ŞANLIOĞLU SALİH,ŞANLIOĞLU AHTER DİLŞADCollaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy. Versailles, FRANCE29.10.2012Özet bildiri, Basılı, VERSAİLLES
45Additional t(33) (q29q23) t (411) (q21q23) t (1118) (q10q10) translocations in a patient with chronic phase Ph CMLÇETİN ZAFER,SALİM OZAN,AYDIN ACAR ÇİĞDEM,YÜCEL ORHAN KEMAL,ÜNDAR LEVENT,KARAÜZÜM SİBELIII. International Eurasian Hematology Congress.21.10.2012Özet bildiri, Basılı, ANTALYA
46Analysis of molecular cytogenetic markers and clinical outcome in chronic lymphocytic leukemia and multiple myeloma with 17p deletion A single center experienceKARAÜZÜM SİBEL,SALİM OZAN,ÇETİN ZAFER,AYDIN ACAR ÇİĞDEM,YÜCEL ORHAN KEMAL,TİMURAĞAOĞLU AYŞEN,KARADOĞAN İHSAN,ÜNDAR LEVENTIII. International Eurasian Hematology Congress.21.10.2012Özet bildiri, Basılı, ANTALYA
47Cytogenetic and molecular cytogenetic findings in chronic lymphocytic leukemıa A single center experienceAYDIN ACAR ÇİĞDEM,SALİM OZAN,ÇETİN ZAFER,YÜCEL ORHAN KEMAL,TİMURAĞAOĞLU AYŞEN,KARADOĞAN iHSAN,ÜNDAR LEVENT,KARAÜZÜM SİBELIII. International Eurasian Hematology Congress.21.10.2012Özet bildiri, Basılı, ANTALYA
48NOD (Non-Obese Diabetic )Farelerde Streptozotosin veya Siklofosfamid ile Hızlandırılmış Tip 1 Diyabet Gelişim Sürecinde Pankreatik Asinar Hücrelerde Farklı TRAIL Ligand ve Reseptör Ekspresyon PaternleriDİRİCE ERCÜMENT,KAHRAMAN SEVİM,ELPEK GÜLSÜM ÖZLEM,AYDIN ACAR ÇİĞDEM,BALCI MUSTAFA KEMAL,ÖMER ABDULKADİR,ŞANLIOĞLU SALİH,ŞANLIOĞLU AHTER DİLŞADXII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi30.10.2011Özet bildiri, Basılı, ANTALYA
49The outcome of TRAIL presentation on T cells in patients with multiple myelomaHAPİL ZEVKLİLER FATMA ZEHRA,BİŞGİN ATIL,AYDIN ACAR ÇİĞDEM,ÜNDAR LEVENT,ŞANLIOĞLU AHTER DİLŞAD,ŞANLIOĞLU SALİH18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy. Milan, ITALY25.10.2010Özet bildiri, Basılı,
50Distinctive expression profiles of TRAIL and TRAIL receptors in patients with endometrial carcinomaAYDIN ACAR ÇİĞDEM,BİŞGİN ATIL,ŞANLIOĞLU AHTER DİLŞAD,PEŞTERELİ HADİCE ELİF,ERDOĞAN GÜLGÜN,ÖZBUDAK İREM HİCRAN,ŞİMŞEK TAYUP,ŞANLIOĞLU SALİH18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy. Milan, ITALY25.10.2010Özet bildiri, Basılı, MİLANO
51Endometrial hyperplasia features distinctive TRAIL and TRAIL receptor expression profilesAYDIN ACAR ÇİĞDEM,BİŞGİN ATIL,ŞANLIOĞLU AHTER DİLŞAD,PEŞTERELİ HADİCE ELİF,ERDOĞAN GÜLGÜN,ÖZBUDAK İREM HİCRAN,ŞİMŞEK TAYUP,ŞANLIOĞLU SALİH18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy.25.10.2010Özet bildiri, Basılı, MİLANO
52The importance of sTRAIL in patients with rheumatoid arthritisBİŞGİN ATIL,TERZİOĞLU MUSTAFA ENDER,ERBASAN FUNDA,AYDIN ACAR ÇİĞDEM,ŞANLIOĞLU SALİH18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy.25.10.2010Özet bildiri, Basılı, MİLANO
53Trail profile of synoviocytes and peripheral blood lymphocytes of rheumatoid arthritis patientsBİŞGİN ATIL,ŞANLIOĞLU AHTER DİLŞAD,YOLDAŞ ÇELİKTEN ŞÜKRAN BURÇAK,AYDIN ACAR ÇİĞDEM,YAZISIZ VELİ,TÜZÜNER SEDAT,GORCZYNSKI REGINALD,AKDİŞ ALİ CEZMİ,TERZİOĞLU MUSTAFA ENDER,ŞANLIOĞLU SALİH18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy.25.10.2010Özet bildiri, Basılı, MİLANO
54Non Obese Diabetic (NOD) farelerde streptozotosin veya siklofosfamid ile indüklenen diyabette T1D in moleküler patogenezinin aydınlatılmasına yönelik bulgularKAHRAMAN SEVİM,DİRİCE ERCÜMENT,ELPEK GÜLSÜM ÖZLEM,AYDIN ACAR ÇİĞDEM,BALCI MUSTAFA KEMAL,ÖMER ABDULKADİR,ŞANLIOĞLU SALİH,ŞANLIOĞLU AHTER DİLŞAD46.Ulusal Diyabet Kongresi14.05.2010Özet bildiri, Basılı, ANTALYA
55Diagnostic significance of serum sTRAIL in rheumatoid arthritisBİŞGİN ATIL,AYDIN ACAR ÇİĞDEM,ERBASAN FUNDA,TERZİOĞLU MUSTAFA ENDER,ŞANLIOĞLU SALİHCombined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research.25.11.2009Özet bildiri, Basılı, HANNOVER
56Tracing of the fate of allogeneic islet grafts via CCD cameraKAHRAMAN SEVİM,HAPİL ZEVKLİLER FATMA ZEHRA,AYDIN ACAR ÇİĞDEM,BİŞGİN ATIL,DİRİCE ERCÜMENT,GRIFFITH THOMAS,ŞANLIOĞLU AHTER DİLŞAD,ŞANLIOĞLU SALİHCombined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research.25.11.2009Özet bildiri, Basılı, HANNOVER
57TRAIL death receptor 4 and decoy receptors expression on CD8 T cells correlate with the disease severity in rheumatoid arthritis patientsBİŞGİN ATIL,TERZİOĞLU MUSTAFA ENDER,AYDIN ACAR ÇİĞDEM,YAZISIZ VELİ,BALCI NİLÜFER,BAĞCI HÜSEYİN,GORCZYNSKI REGINALD,AKDİŞ ALİ CEZMİ,ŞANLIOĞLU SALİHCombined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research. Hannover, GERMANY25.11.2009Özet bildiri, Basılı,
58Increased sTRAIL levels were correlated with patient survival in BevacizumAb treated metastatic colon cancer patientsBİŞGİN ATIL,KARGI AYŞEGÜL,YALÇIN ARZU,AYDIN ACAR ÇİĞDEM,SAVAŞ BURHAN,ŞANLIOĞLU SALİHCombined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research.Hannover, GERMANY25.11.2009Özet bildiri, Basılı,
59Serum sTRAIL konsantrasyonunun romatoid artrit tanısındaki yeriBİŞGİN ATIL,AYDIN ACAR ÇİĞDEM,ERBASAN FUNDA,TERZİOĞLU MUSTAFA ENDER,ŞANLIOĞLU SALİHXI. Ulusal Tıbbi Biyoloji ve Genetik Kongresi31.10.2009Özet bildiri, Basılı, MUĞLA
60Increased sTRAIL levels were correlated with patient survival in BevacizumAb treated metastatic colon cancer patientsBİŞGİN ATIL,KARGI AYŞEGÜL,YALÇIN ARZU,AYDIN ACAR ÇİĞDEM,SAVAŞ BURHAN,ŞANLIOĞLU SALİH34th Congress of the Federation-of-European-Biochemical-Societies.09.07.2009Özet bildiri, Basılı, PRAG
61Rheumatoid Arthritis disease activity is correlated with TRAIL death receptor 4 and decoy receptor expresions on CD8 T cellsBİŞGİN ATIL,TERZİOĞLU MUSTAFA ENDER,AYDIN ACAR ÇİĞDEM,YAZISIZ VELİ,BALCI NİLÜFER,BAĞCI HÜSEYİN,GORCYNSKI REGINALD,AKDİŞ ALİ CEZMİ,ŞANLIOĞLU SALİH34th Congress of the Federation-of-European-Biochemical-Societies.09.07.2009Özet bildiri, Basılı, PRAG
62Gene therapy mediated apoptosis inducing approaches employing Ad5hTRAIL and a DCR2 siRNA strategy in lung cancer patientsAYDIN ACAR ÇİĞDEM,ŞANLIOĞLU AHTER DİLŞAD,KARAÇAY BAHRİ,ÖZBİLİM GÜLAY,DERTSİZ LEVENT,ÖZBUDAK ÖMER,AKDİŞ ALİ CEZMİ,ŞANLIOĞLU SALİH3. Klinik Pratikte Kök Hücre ve Gen Tedavisi Kongresi01.06.2008Özet bildiri, Basılı, İSTANBUL
63Gene therapy mediated apoptosis inducing approaches employing Ad5hTRAIL and a DCR2 siRNA strategy in lung cancer patientsAYDIN ACAR ÇİĞDEM,ŞANLIOĞLU AHTER DİLŞAD,KARAÇAY BAHRİ,ÖZBİLİM GÜLAY,DERTSİZ LEVENT,ÖZBUDAK ÖMER,AKDİŞ ALİ CEZMİ,ŞANLIOĞLU SALİHII. Multidisipliner Kanser Araştırma Sempozyumu. Uludağ-Bursa27.02.2008Özet bildiri, Basılı, BURSA
64Fundamental principles of tumor necrosis factor alpha gene therapy approach and implications for patients with lung carcinomaŞANLIOĞLU AHTER DİLŞAD,AYDIN ACAR ÇİĞDEM,BOZCUK HAKAN,TERZİOĞLU MUSTAFA ENDER,ŞANLIOĞLU SALİHGene Therapy Symposium.03.11.2007Özet bildiri, Basılı, İSTANBUL
65A DcR2 siRNA strategy employing three different siRNA constructs in combination defeats adenovirus transferred TRAIL resistance in lung cancer cellsAYDIN ACAR ÇİĞDEM,ŞANLIOĞLU AHTER DİLŞAD,KARAÇAY BAHRİ,ÖZBİLİM GÜLAY,DERTSİZ LEVENT,ÖZBUDAK ÖMER,AKDİŞ ALİ CEZMİ,ŞANLIOĞLU SALİHGene Therapy Symposium.03.11.2007Özet bildiri, Basılı, İSTANBUL
66A DcR2 siRNA strategy employing three different siRNA constructs in combination defeats adenovirus transferred TRAIL resistance in lung cancer cellsAYDIN ACAR ÇİĞDEM,ŞANLIOĞLU AHTER DİLŞAD,KARAÇAY BAHRİ,ÖZBİLİM GÜLAY,DERTSİZ LEVENT,ÖZBUDAK ÖMER,AKDİŞ ALİ CEZMİ,ŞANLIOĞLU SALİHX. Ulusal Tıbbi Biyoloji ve Genetik Kongresi.09.09.2007Özet bildiri, Basılı, ANTALYA
67A DcR2 siRNA strategy employing three different siRNA constructs in combination defeats adenovirus transferred TRAIL resistance in lung cancer cellsAYDIN ACAR ÇİĞDEM,KARAÇAY BAHRİ,ÖZBİLİM GÜLAY,DERTSİZ LEVENT,ÖZBUDAK ÖMER,AKDİŞ ALİ CEZMİ,ŞANLIOĞLU SALİHXIV Annual Congress of the European Society of Gene Therapy.12.11.2006Özet bildiri, Basılı, ATİNA
68DcR2 siRNA approach defeats TRAIL resistance in lung cancer cellsAYDIN ACAR ÇİĞDEM,ÖZBUDAK ÖMER,DERTSİZ LEVENT,ÖZBİLİM GÜLAY,AKDİŞ ALİ CEZMİ,ŞANLIOĞLU SALİH31st Congress of the Federation-of-European-Biochemical-Societies (FEBS)29.06.2006Özet bildiri, Basılı, İSTANBUL
69DcR2 siRNA yaklaşımı A549 akciğer kanser hücrelerini adenovirus aracılı TRAIL transferlerine duyarlı kılarAYDIN ACAR ÇİĞDEM,ŞANLIOĞLU AHTER DİLŞAD,ÖZBUDAK ÖMER,DERTSİZ LEVENT,ŞANLIOĞLU SALİHIX. Ulusal Tıbbi Tıbbi Biyoloji Kongresi27.11.2005Özet bildiri, Basılı, MANİSA
70A DcR2 siRNA approach overcomes TRAIL resistance in A549 lung cancer cellsAYDIN ACAR ÇİĞDEM,ŞANLIOĞLU AHTER DİLŞAD,ÖZBUDAK ÖMER,DERTSİZ LEVENT,ŞANLIOĞLU SALİHXIII Annual Congress of the European Society of Gene Therapy.01.11.2005Özet bildiri, Basılı, PRAG
71Surface TRAIL Decoy Receptor 4 expression constitutes a resistance to adenovirus delivery of TRAIL in MCF7 Breast Cancer cellsŞANLIOĞLU SALİH,ŞANLIOĞLU AHTER DİLŞAD,DİRİCE ERCÜMENT,AYDIN ACAR ÇİĞDEM,ERİN NURAY,KÖKSOY SADİXIII Annual Congress of the European Society of Gene Therapy.01.11.2005Özet bildiri, Basılı, PRAG
72A novel death ligand mediated gene therapy approach for patients with lung cancerAYDIN ACAR ÇİĞDEM,ŞANLIOĞLU AHTER DİLŞAD,DİRİCE ERCÜMENT,DERTSİZ LEVENT,ÖZBUDAK ÖMER,ŞANLIOĞLU SALİHAdvances in Molecular Medicine, 1. Moleküler Tıp Kongresi19.04.2005Özet bildiri, Basılı, İSTANBUL
73Surface TRAIL Receptor 4 expression correlates with TRAIL resistance in breast cancer cellsŞANLIOĞLU AHTER DİLŞAD,DİRİCE ERCÜMENT,AYDIN ACAR ÇİĞDEM,ERİN NURAY,KÖKSOY SADİ,ŞANLIOĞLU SALİHAdvances in Molecular Medicine, 1. Moleküler Tıp Kongresi19.04.2005Özet bildiri, Basılı, İSTANBUL
74The therapeutical effect of recombinant adenovirus mediated TRAIL gene therapy method in lung cancerAYDIN ACAR ÇİĞDEM,ŞANLIOĞLU AHTER DİLŞAD,DİRİCE ERCÜMENT,ŞANLIOĞLU SALİHXII Annual Congress of the European Society of Gene Therapy07.11.2004Özet bildiri, Basılı, TAMPERE
75Fundamental principles of tumor necrosis factor alpha gene therapy approach and implications for patients with lung carcinomaŞANLIOĞLU AHTER DİLŞAD,AYDIN ACAR ÇİĞDEM,BOZCUK HAKAN,TERZİOĞLU MUSTAFA ENDER,ŞANLIOĞLU SALİHXII Annual Congress of the European Society of Gene Therapy.07.11.2004Özet bildiri, Basılı, TAMPERE
76Akciğer kanserinde recombinant adenovirus aracılı TRAIL gen tedavi metodunun geliştirilmesiAYDIN ACAR ÇİĞDEM,ŞANLIOĞLU AHTER DİLŞAD,DİRİCE ERCÜMENT,ŞANLIOĞLU SALİHI.Ulusal Klinik Pratikte Kök Hücre ve Gen Tedavi kongresi09.05.2004Özet bildiri, Basılı, İSTANBUL